Landewé R, Sieper J, Mease P, et al. Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA). EULAR 2018. Abstract OP0334.
Nieuwe EULAR- en GRAPPA-richtlijnen voor PsA: zoek de verschillen
feb 2017 | Arthritis psoriatica